HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Eye Manifestations (Manifestations, Eye)

Subscribe to New Research on Eye Manifestations

Ocular disorders attendant upon non-ocular disease or injury.

Also Known As:

Manifestations, Eye; Eye Manifestation; Manifestation, Eye

Networked: 25 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1.	Rheumatoid Arthritis
2.	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
3.	Scleritis (Episcleritis)
4.	Vasculitis (Vasculitides)
5.	Toxoplasmosis

Experts

1.	Castañeda, Santos: 1 article (11/2015)
2.	Garcia-Hernandez, Francisco Jose: 1 article (11/2015)
3.	González-Escribano, Maria-Francisca: 1 article (11/2015)
4.	Fanlo, Patricia: 1 article (11/2015)
5.	García-Lozano, José-Raul: 1 article (11/2015)
6.	Sánchez-Bursón, Juan: 1 article (11/2015)
7.	Martin, Javier: 1 article (11/2015)
8.	Ortiz-Fernandez, Lourdes: 1 article (11/2015)
9.	García-Hernández, Francisco-Jose: 1 article (11/2015)
10.	Camps, Teresa: 1 article (11/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Eye Manifestations:

1.	SteroidsIBA 01/01/2015 - "After the combined administration of antibiotics and steroids, her symptoms gradually improved, but not all of her eye manifestations resolved. "
2.	Anti-Bacterial Agents (Antibiotics)IBA 01/01/2015 - "After the combined administration of antibiotics and steroids, her symptoms gradually improved, but not all of her eye manifestations resolved. "
3.	Rheumatoid FactorIBA 05/01/2008 - "Antinuclear antibodies (ANA) and rheumatoid factor (RF) as well as illness duration and age at diagnosis had no influence in the appearance of eye manifestations. " 05/01/2008 - "To study the prevalence of eye manifestations in the local rheumatoid arthritis (RA) population, as well as to know if the presence of rheumatoid factor (RF) and antinuclear antibodies (ANA) affect this profile. "
4.	Antinuclear AntibodiesIBA 05/01/2008 - "Antinuclear antibodies (ANA) and rheumatoid factor (RF) as well as illness duration and age at diagnosis had no influence in the appearance of eye manifestations. " 05/01/2008 - "To study the prevalence of eye manifestations in the local rheumatoid arthritis (RA) population, as well as to know if the presence of rheumatoid factor (RF) and antinuclear antibodies (ANA) affect this profile. "
5.	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/01/2007 - "The medical records of four consecutive patients with pANCA (MPO-ANCA) vasculitis who showed eye manifestations were retrospectively reviewed. " 03/01/2007 - "Eye manifestations in patients with perinuclear antineutrophil cytoplasmic antibody-associated vasculitis: case series and literature review." 03/01/2007 - "ANCA testing including both pANCA and cytoplasmic pattern antineutrophil cytoplasmic antibody would help establish a systemic diagnosis in patients with eye manifestations such as scleritis, retinal vein occlusion, optic neuropathy, or APMPPE." 03/01/2007 - "To report and summarize eye manifestations of patients with perinuclear pattern antineutrophil cytoplasmic antibody [pANCA, myeloperoxidase (MPO)-ANCA]-associated vasculitis. "
6.	Methacholine Chloride (Methacholine)FDA Link 07/01/2006 - "They chose 30 patients who had proven skin or eye manifestations secondary to SMG, and performed baseline and provocative pulmonary function testing with cold air and methacholine. "
7.	HLA-B Antigens (HLA-B)IBA 11/01/2015 - "The distribution of the risk alleles was similar in patients with and without eye manifestations and in patients with and without HLA-B*51. "
8.	Vitamin A (Retinol)FDA LinkGeneric 07/01/1958 - "Eye manifestations of chronic vitamin A intoxication."
9.	Antithyroid Agents (Antithyroid Drugs)IBA 01/01/1992 - "Antithyroid drugs may improve eye manifestations, possibly by restoring normal thyroid function and reducing orbit-directed autoimmune reactions, whereas ophthalmopathy may worsen after radioiodine administration or thyroidectomy. "
10.	Retinaldehyde (Retinal)IBA 11/01/1985 - "Eye manifestations include retinal phakomata which may be granular, white and calcified, or flat, translucent and noncalcified. "

Therapies and Procedures

1.	Transplants (Transplant) 08/01/2006 - "Dry eye manifestation occurred in 32% of patients and was positively correlated with age over 27 years (P = 0.05), peripheral blood progenitor cell transplant (P = 0.002), chronic graft-versus-host disease (P = 0.0027), and chronic or acute myeloid leukaemia (P = 0.001). "
2.	Photopheresis 11/01/2007 - "This prospective study was designed to describe eye manifestations of cGVHD in a large series of patients monitoring them before and after 1 year of extracorporeal photochemotherapy (ECP). "
3.	Thyroidectomy 01/01/1992 - "Antithyroid drugs may improve eye manifestations, possibly by restoring normal thyroid function and reducing orbit-directed autoimmune reactions, whereas ophthalmopathy may worsen after radioiodine administration or thyroidectomy. "
4.	Plasma Exchange 05/15/1982 - "[Value of plasma exchange in the treatment of Behcet's syndrome and its eye manifestations]."
5.	Renal Dialysis (Hemodialysis) 01/01/1972 - "[Eye manifestations during periodic hemodialysis]."